Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLCMarcelo V. Negrão, Sandip Pravin Patel, Lukas Delasos et al.|Cancer Discovery|2023Cited by 181
Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell CarcinomaGlenn J. Hanna, Eleni M. Rettig, Michael J. Dennis et al.|Clinical Cancer Research|2024Cited by 48
A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinomaMichael J. Dennis, Kathryn A. Gold, Assuntina G. Sacco et al.|Oral Oncology|2022Cited by 21